Free tool
Largest one day gains
The 50 largest one day percentage moves higher recorded at the latest close. The largest moves were BTSG at +7.2% and SMMT at +6.5%. By size, the list splits into 50 large cap listings.
Switch view
All stocks50 of 23,178 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1D return | 1Y return |
|---|---|---|---|---|---|
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +7.20% | +156.37% |
| SMMT | Summit Therapeutics Inc. | $11.35B | Large cap | +6.51% | −42.63% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $12.45B | Large cap | +5.22% | +26.78% |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +3.64% | +169.17% |
| I1LM34.SA | Illumina, Inc. | $34.10B | Large cap | +3.50% | +113.13% |
| U1HS34.SA | Universal Health Services, Inc. | $10.55B | Large cap | +3.39% | −6.44% |
| ARGX | argenx SE | $65.51B | Large cap | +2.71% | +47.90% |
| MDLN | Medline Inc. | $46.53B | Large cap | +2.71% | −13.07% |
| DVAI34.SA | DaVita Inc. | $11.70B | Large cap | +2.70% | +18.80% |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +2.54% | +704.28% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | $44.24B | Large cap | +2.35% | +94.70% |
| CYTK | Cytokinetics, Incorporated | $11.01B | Large cap | +2.25% | +109.36% |
| NBIX | Neurocrine Biosciences, Inc. | $15.92B | Large cap | +2.10% | +13.36% |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +1.92% | +466.35% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | $31.78B | Large cap | +1.82% | −49.35% |
| UHS | Universal Health Services, Inc. | $10.53B | Large cap | +1.67% | −1.76% |
| H1CA34.SA | HCA Healthcare, Inc. | $92.89B | Large cap | +1.61% | +2.99% |
| GILD34.SA | Gilead Sciences, Inc. | $184.15B | Large cap | +1.43% | −79.11% |
| DVA | DaVita Inc. | $11.41B | Large cap | +1.27% | +30.89% |
| BMYB34.SA | Bristol-Myers Squibb Company | $138.65B | Large cap | +1.25% | +40.74% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +1.21% | +42.93% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.34B | Large cap | +1.14% | −4.32% |
| KRYS | Krystal Biotech, Inc. | $10.65B | Large cap | +1.00% | +143.67% |
| C1AH34.SA | Cardinal Health, Inc. | $55.77B | Large cap | +0.97% | +52.41% |
| MDT | Medtronic plc | $117.78B | Large cap | +0.97% | +2.29% |
| ELV | Elevance Health, Inc. | $87.30B | Large cap | +0.92% | +32.12% |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +0.90% | +5.01% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +0.85% | +50.70% |
| AXSM | Axsome Therapeutics, Inc. | $10.85B | Large cap | +0.81% | +69.99% |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +0.81% | +31.02% |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +0.81% | +38.51% |
| MEDP | Medpace Holdings, Inc. | $17.28B | Large cap | +0.81% | +30.74% |
| BAX | Baxter International Inc. | $13.70B | Large cap | +0.80% | +8.90% |
| VTRS | Viatris Inc. | $19.35B | Large cap | +0.78% | +66.19% |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +0.77% | +206.51% |
| CNC | Centene Corporation | $32.34B | Large cap | +0.72% | +127.01% |
| IDXX | IDEXX Laboratories, Inc. | $43.66B | Large cap | +0.62% | −13.64% |
| MOH | Molina Healthcare, Inc. | $10.57B | Large cap | +0.57% | +13.35% |
| CI | The Cigna Group | $74.22B | Large cap | +0.55% | −4.84% |
| EHC | Encompass Health Corporation | $11.92B | Large cap | +0.53% | −1.75% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +0.52% | +107.59% |
| DHER34.SA | Danaher Corporation | $151.72B | Large cap | +0.43% | +0.89% |
| WST | West Pharmaceutical Services, Inc. | $24.63B | Large cap | +0.41% | +42.61% |
| INSM | Insmed Incorporated | $27.16B | Large cap | +0.40% | −7.54% |
| MDTC34.SA | Medtronic plc | $118.37B | Large cap | +0.40% | −75.74% |
| Z1TS34.SA | Zoetis Inc. | $32.03B | Large cap | +0.40% | −52.31% |
| HUM | Humana Inc. | $46.96B | Large cap | +0.35% | +33.14% |
| ZTS | Zoetis Inc. | $32.03B | Large cap | +0.30% | −49.50% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +0.27% | +308.99% |
| SNN | Smith & Nephew plc | $12.23B | Large cap | +0.27% | −19.49% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Micro and small cap listings are left out, so the list describes the market rather than thin trading, as are moves beyond 1,000% in a session, which are corporate actions the price series has not been restated for. This is a description of one day of price movement, nothing more. It says nothing about any company behind it.